Skip to main content
. Author manuscript; available in PMC: 2012 Aug 18.
Published in final edited form as: Vaccine. 2011 Apr 19;29(36):6113–6124. doi: 10.1016/j.vaccine.2011.04.013

Figure 4. Sensitivity analysis of vaccine efficacy.

Figure 4

Sensitivity analysis of variations in constant vaccine efficacy on (a) incremental costs, QALYs, and (b) incremental cost-effectiveness ratios, assuming a vaccine price of $500 (solid line) or $250 (dashed line) is shown. Assumes universal one-time vaccination with 60% coverage, and constant vaccine efficacy with lifetime duration of protection. QALY = quality adjusted life year.